Bank of America
MGRM

Bank of America’s Monogram Orthopaedics MGRM Stock Holding History

Bank of America’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,722
Closed -$204K – 7992
2025
Q3 		$204K Buy
34,722
+31,992
+1,172% +$171K ﹤0.01% 6268
2025
Q2 		$7.89K Buy
2,730
+45
+2% +$121 ﹤0.01% 7233
2025
Q1 		$7.89K Buy
2,685
+8
+0.3% +$21 ﹤0.01% 7155
2024
Q4 		$6.34K Buy
2,677
+13
+0.5% +$30 ﹤0.01% 7060
2024
Q3 		$7.06K Sell
2,664
-1,254
-32% -$3.27K ﹤0.01% 6954
2024
Q2 		$8.42K Buy
3,918
+2,338
+148% +$5.13K ﹤0.01% 6922
2024
Q1 		$3.85K Buy
1,580
+162
+11% +$478 ﹤0.01% 7035
2023
Q4 		$4.88K Sell
1,418
-100
-7% -$301 ﹤0.01% 7014
2023
Q3 		$3.95K Buy
1,518
+1,418
+1,418% +$5.97K ﹤0.01% 7042
2023
Q2 		$398 Buy
+100
New +$517 ﹤0.01% 7339

Bank of America's MGRM Position: Q4 2025 in Review

Bank of America sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 34,722 shares — an estimated $204K sold.

Bank of America first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $204K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Bank of America reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 34,722 Monogram Orthopaedics shares in Q4 2025, an estimated $204K.
  • Bank of America first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
  • Bank of America's Monogram Orthopaedics position peaked at $204K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.